Cantourage Group SE Logo

Cantourage Group SE

HIGH | XMIL

Overview

Corporate Details

ISIN(s):
DE000A3DSV01
LEI:
3912003NCTLO6YHA9V48
Country:
Germany
Address:
Feurigstraße 54, 10827 Berlin
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cantourage Group SE is a leading European medical cannabis company that produces and distributes cannabis-based medicinal preparations. Founded in 2019, the company operates a 'fast-track' platform model, sourcing cannabis flowers and raw materials from a global network of cultivation partners. It manages the import and processing of these materials into EU-compliant pharmaceutical products at its European manufacturing hubs, handling all regulatory complexities. The product portfolio includes dried flowers, extracts, dronabinol, and pharma-grade cannabidiol, which are distributed to pharmacies through wholesalers. Cantourage also facilitates patient access to medical cannabis therapies through its telemedicine platform, Telecan.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Cantourage Group SE. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-09 18:42
Board/Management Information
Ad-hoc-Mitteilung nach Art. 17 Marktmissbrauchsverordnung - Cantourage Group SE…
German 4.6 KB
2025-05-20 07:51
Earnings Release
Cantourage achieves strong and profitable growth in the first quarter of 2025
English 7.4 KB
2025-05-15 07:07
Earnings Release
Cantourage achieves another record revenue: EUR 11.1 million in April 2025
English 6.6 KB
2025-04-11 09:03
Earnings Release
Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 202…
English 6.8 KB
2025-04-10 08:52
Earnings Release
Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 for the fi…
English 9.0 KB
2025-03-11 08:31
Earnings Release
Cantourage Group SE: Starker Jahresendspurt und anhaltendes Wachstum in 2025
German 7.6 KB
2025-03-10 08:31
Earnings Release
Cantourage Group SE: Starker Jahresendspurt und anhaltendes Wachstum in 2025
German 7.6 KB
2025-01-16 07:30
Earnings Release
Legalization of cannabis brings strong growth: Cantourage Group SE increases it…
English 10.0 KB
2025-01-15 07:31
Earnings Release
Cantourage Group SE ubertrifft Prognose und steigert Umsatz um 118 % auf EUR 51…
German 8.0 KB
2025-01-15 07:30
Earnings Release
Legalization of cannabis brings strong growth: Cantourage Group SE increases it…
English 11.2 KB
2025-01-14 07:31
Earnings Release
Cantourage Group SE ubertrifft Prognose und steigert Umsatz um 118 % auf EUR 51…
German 8.0 KB
2024-12-20 08:00
M&A Activity
Cantourage Group SE exports medical craft cannabis for the first time to the gr…
English 10.6 KB
2024-12-19 08:00
Regulatory News Service
Cantourage Group SE exports medical craft cannabis for the first time to the gr…
English 10.6 KB
2024-12-13 08:00
Earnings Release
Cantourage Group SE verzeichnet starke Geschaftsentwicklung im November und erh…
German 11.1 KB
2024-12-12 08:00
Earnings Release
Cantourage Group SE verzeichnet starke Geschaftsentwicklung im November und erh…
German 11.1 KB

Automate Your Workflow. Get a real-time feed of all Cantourage Group SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cantourage Group SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-02 Think.Health Projekt M GmbH & Co. KG Close relation Sell None 72,010.80 EUR
2024-11-25 PiFriva Verwaltungs- und Beteiligungs-GmbH Close relation Sell None 200,000.00 EUR
2024-09-13 PiFriva Verwaltungs- und Beteiligungs-GmbH Close relation Sell None 105,000.00 EUR
2024-07-18 PiFriva Verwaltungs- und Beteiligungs-GmbH Close relation Sell None 140,000.00 EUR
2024-06-06 HOFY4 GmbH Close relation Sell None 345,000.00 EUR
2024-05-27 HOFY4 GmbH Close relation Sell None 7,400.00 EUR
2024-05-17 HOFY4 GmbH Close relation Sell None 140,000.00 EUR
2024-05-17 HOFY4 GmbH Close relation Sell None 1,080.00 EUR
2024-02-21 HOFY4 GmbH Close relation Sell None 63,205.88 EUR
2024-02-14 Think.Health Projekt M GmbH & Co. KG Close relation Sell None 82,415.57 EUR

Peer Companies

Company Country Ticker View
Rekah Pharmaceutical Prod Ltd. Logo
Integrated generic pharma maker of Rx/OTC drugs, devices & cosmetics with global distribution.
Israel REKA
Renascience Inc. Logo Japan 4889
Replek AD Logo
Global manufacturer of generic medicines, cosmetics, and cannabis-based products.
North Macedonia REPL
Japan 4591
Roche Holding AG Logo
A global leader in pharmaceuticals and diagnostics, advancing personalized healthcare.
Switzerland RO
ROHTO PHARMACEUTICAL CO.,LTD. Logo Japan 4527
Ropharma S.A. Logo
An integrated pharma company: manufacturing, distributing, and retailing health products.
Romania RPH
Develops and produces in-vitro diagnostic kits for molecular biology and microbiology.
Türkiye RTALB
SanBio Company Limited Logo Japan 4592
Sanofi Logo
A global biopharmaceutical firm developing and marketing innovative medicines and vaccines worldwide.
France SAN